Series A - ProJenX
Investment Firm
Overview
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Announced Date
Nov 02, 2023
Closed on Date
Nov 02, 2023
Funding Type
Series A
Highlights
Location
New York, United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
ProJenX raised $15000000 on 2023-11-02 in Series A
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 02, 2023 |  Series A - ProJenX | 1 | - | 15.0M |
| Feb 16, 2022 | Seed Round - ProJenX | 1 | - | 5.1M |
| Jun 20, 2024 | Grant - ProJenX | 1 | - | 1.0M |
Recent Activity
There is no recent news or activity for this profile.